Subscribe via email:
7 Hot Stocks, Medical Products in Focus
Posted by Blain Reinkensmeyer
January 28, 2008 at 1:19 pm
Whether or not you know this, Medical companies are coming into favor, but is your portfolio ready to maximize the opportunity?
Here are 7 different companies involved in the distribution and sales of Medical Products that you should know about and watch. All stock charts are daily 6 month views.
Bard Medical (BCR) stock. Last $92.68.
Recent upgrades and positive news for strong growth in 2008 has sent this stock soaring. $90 is key support moving forward and Bard is a buy wherever you can grab it. 5 - 8% stops.
Click to View Full ChartExactech (EXAC) stock. Last $23.16.
Already broken out, be cautious though with taking positions as stock only averages 39,600 shares traded per day.
Click to View Full ChartMeridian Bioscience (VIVO) stock. Last $32.51.
I would wait for the stock to move back towards $35 before considering a position. 50 MA is support.
Click to View Full ChartNuvasive (NUVA) stock. Last $41.57.
NUVA is a buy above $42.20, 5 - 8% stops sufficient.
Click to View Full ChartBaxter International (BAX) stock. Last $61.21.
I like this stock right here at $61.21. Stop can be as tight as $60.40, or as “loose” as $59.10 (still only 3.4%).
Click to View Full ChartSt Jude Medical (STJ) stock. Last $40.95.
This chart needs some more work, but the now uptrending 50 MA is a good start. With other stocks mentioned here looking brighter, I wouldn’t consider STJ until atleast a cross back above $44.
Click to View Full ChartMerit Medical Systems (MMSI) stock. Last $16.68.
Pulling up a weekly view of MMSI will reveal a high of $16.79 on 12/08/07. This is your resistance moving forward, high on the day right now for MMSI is $16.75. MMSI is also another low volume trading stock, with a market cap of just $452 million you need to be careful with any position.
Click to View Full ChartThis industry is consolidating right now which is a good sign of growth overall. Bard recently acquired a product known as Lifestent from Edwards Lifesciences, and Respironics (RESP) was recently acquired for some $5 billion dollars.
I like NUVA the best of these stocks. I’m also a fan of HOLX, which really is building a terrific monopoly in women’s health. Healthcare is a great area of growth.
Very Interesting
[...] $100. Buying some in here with a tight stop and adding at $101 would be a good play. Featured Bard last week as well. — 02/14/08 Close $97.56 [...]